Kinnate Biopharma Inc.
NASDAQ:KNTE
2.65 (USD) • At close April 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 56.998 | 51.662 | 34.507 | 73.57 | 29.261 | 34.502 | 35.065 | 33.099 | 116.096 | 135.009 | 132.991 | 182.389 | 365.462 | 156.859 | 76.453 |
| Short Term Investments
| 97.036 | 115.914 | 150.196 | 127.411 | 172.214 | 196.477 | 197.93 | 206.164 | 103.362 | 88.219 | 87.017 | 65.808 | 31.398 | 0 | 0 |
| Cash and Short Term Investments
| 154.034 | 167.576 | 184.703 | 200.981 | 201.475 | 230.979 | 232.995 | 239.263 | 219.458 | 223.228 | 220.008 | 248.197 | 396.86 | 156.859 | 76.453 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.973 | 0 | 0.973 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.973 | 0 | 0 |
| Other Current Assets
| 4.143 | 2.725 | 3.897 | 4.307 | 3.637 | 3.727 | 4.718 | 4.935 | 5.639 | 3.176 | 3.761 | 2.975 | 3.343 | 0.62 | 0.025 |
| Total Current Assets
| 158.177 | 170.301 | 188.6 | 205.288 | 230.837 | 261.175 | 267.133 | 275.196 | 258.69 | 260.712 | 258.78 | 251.172 | 400.203 | 157.479 | 77.451 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 4.76 | 5.13 | 5.625 | 6.047 | 6.448 | 6.752 | 7.073 | 7.192 | 0.956 | 0.291 | 0.286 | 0.283 | 0.368 | 0.316 | 0.154 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 10.63 | 12.762 | 19.579 | 30.203 | 39.139 | 31.097 | 46.604 | 63.131 | 105.449 | 124.636 | 145.136 | 134.91 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.038 | 2.516 | 2.331 | 2.342 | 2.402 | 3.109 | 3.086 | 3.101 | 1.769 | 0.69 | 0.461 | 0 | 0 | 1.402 | 0 |
| Total Non-Current Assets
| 15.428 | 20.408 | 27.535 | 38.592 | 47.989 | 40.958 | 56.763 | 73.424 | 108.174 | 125.617 | 145.883 | 135.193 | 0.368 | 1.718 | 0.154 |
| Total Assets
| 173.605 | 190.709 | 216.135 | 243.88 | 278.826 | 302.133 | 323.896 | 348.62 | 366.864 | 386.329 | 404.663 | 386.365 | 400.571 | 159.197 | 77.605 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 2.031 | 2.929 | 2.696 | 4.451 | 2.97 | 3.058 | 2.016 | 4.419 | 3.148 | 2.724 | 1.334 | 3.212 | 3.94 | 2.328 | 0.956 |
| Short Term Debt
| 0.892 | 0.869 | 0.959 | 0.983 | 0.991 | 0.966 | 0.836 | 0.454 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 9.072 | 11.976 | 12.118 | 12.721 | 13.206 | 11.319 | 8.612 | 8.783 | 9.239 | 7.575 | 6.989 | 4.581 | 3.364 | 4.371 | 0.989 |
| Total Current Liabilities
| 11.995 | 15.774 | 15.773 | 18.155 | 17.167 | 15.343 | 11.464 | 13.656 | 12.387 | 10.299 | 8.323 | 7.793 | 7.304 | 6.699 | 1.945 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 2.283 | 2.515 | 2.742 | 2.963 | 3.191 | 3.449 | 3.703 | 4.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 35 | 35 | 0 | 0 | 0 | 93.146 |
| Total Non-Current Liabilities
| 2.283 | 2.515 | 2.742 | 2.963 | 3.191 | 3.449 | 3.703 | 4.143 | 35 | 35 | 35 | 0 | 0 | 0 | 93.146 |
| Total Liabilities
| 14.278 | 18.289 | 18.515 | 21.118 | 20.358 | 18.792 | 15.167 | 17.799 | 12.387 | 10.299 | 8.323 | 7.793 | 7.304 | 6.699 | 95.091 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.003 | 0 |
| Retained Earnings
| -372.012 | -354.954 | -324.221 | -292.303 | -259.363 | -227.8 | -197.063 | -169.994 | -143.092 | -116.933 | -92.231 | -70.786 | -53.329 | -39.622 | -17.568 |
| Accumulated Other Comprehensive Income/Loss
| -0.012 | -0.147 | -0.342 | -0.464 | -1.41 | -2.559 | -2.737 | -2.18 | -0.524 | -0.036 | -0.074 | -0.04 | -0.009 | 0 | 0 |
| Other Total Stockholders Equity
| 531.346 | 527.516 | 522.178 | 515.524 | 484.237 | 478.696 | 473.525 | 467.991 | 463.089 | 457.995 | 453.641 | 449.394 | 446.601 | 192.117 | 0.082 |
| Total Shareholders Equity
| 159.327 | 172.42 | 197.62 | 222.762 | 223.468 | 248.341 | 273.729 | 295.821 | 319.477 | 341.03 | 361.34 | 378.572 | 393.267 | 152.498 | -17.486 |
| Total Equity
| 159.327 | 172.42 | 197.62 | 222.762 | 258.468 | 283.341 | 308.729 | 330.821 | 319.477 | 341.03 | 361.34 | 378.572 | 393.267 | 152.498 | -17.486 |
| Total Liabilities & Shareholders Equity
| 173.605 | 190.709 | 216.135 | 243.88 | 278.826 | 302.133 | 323.896 | 348.62 | 366.864 | 386.329 | 404.663 | 386.365 | 400.571 | 159.197 | 77.605 |